GYRE - GYRE THERAPEUTICS, INC.
8.85
0.140 1.582%
Share volume: 88,673
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$8.71
0.14
0.02%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-15-2023 | 08-14-2023 | 10-26-2023 | 03-27-2024 | 05-13-2024 | 08-13-2024 | 11-13-2024 | 03-17-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 113.450 M | 27.172 M | 25.225 M | 25.488 M | 27.872 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 4.636 M | 979.000 K | 770.000 K | 958.000 K | 1.177 M | |
| Gross profit | 0.000 | 0.000 | 0.000 | 108.814 M | 26.193 M | 24.455 M | 24.530 M | 26.695 M | |
| nan% | nan% | inf% | -75.93% | -6.64% | 0.31% | 8.83% | |||
| Operating expenses | 4.558 M | 2.543 M | 2.823 M | 79.677 M | 5.580 M | 6.779 M | 6.598 M | 9.176 M | |
| Selling general and admin | 3.970 M | 2.225 M | 2.408 M | 67.218 M | 3.398 M | 3.424 M | 3.823 M | 5.464 M | |
| Research and development | 588.000 K | 318.000 K | 415.000 K | 12.459 M | 2.182 M | 3.355 M | 2.775 M | 3.712 M | |
| Total expenses | 4.558 M | 2.543 M | 2.823 M | 84.313 M | 18.122 M | 21.261 M | 20.297 M | 26.030 M | |
| -44.21% | 11.01% | 2,886.65% | -78.51% | 17.32% | -4.53% | 28.25% | |||
| Operating income | -4.558 M | -2.543 M | -2.823 M | 29.137 M | 8.071 M | 3.262 M | 4.233 M | 597.000 K | |
| Ebit | -4.558 M | -2.543 M | -2.823 M | 29.137 M | 12.153 M | 5.753 M | 3.407 M | 358.000 K | |
| Pretax income | 274.000 K | -2.470 M | -1.576 M | -73.193 M | 12.481 M | 6.035 M | 3.930 M | 772.000 K | |
| -1,001.46% | -36.19% | 4,544.23% | -117.05% | -51.65% | -34.88% | -80.36% | |||
| Income tax | 14.000 K | 2.000 K | 0.000 | 8.499 M | 2.546 M | 1.497 M | 1.074 M | 203.000 K | |
| Net income basic | 260.000 K | -2.472 M | -1.576 M | -89.145 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| -1,050.77% | 36.25% | -5,556.41% | 100.00% | ||||||
| Net income | 260.000 K | -2.472 M | -1.576 M | -89.145 M | 9.935 M | 4.538 M | 2.856 M | 569.000 K | |
| -1,050.77% | 36.25% | -5,556.41% | 111.14% | -54.32% | -37.06% | -80.08% |
